Company / Goodwill
NOVAVAX INC Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$113.5M
FY2025
5-year range
$107.5M / $131.5M
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#36 of 75
Health Care
What the data says
At $113M, NOVAVAX INC's goodwill ranks #36 of 75 in the Health Care sector. Goodwill returned to growth in FY2025 after 2 years of decline, reaching $113M.
Based on SEC 10-K filings.
$113M in FY2025 with a 5-year CAGR of -3.5%.
Declined from $127M to $113M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
#36 of 75 in Health CareTop 48% of 75This company $113.5M Sector average $4.0B
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, goodwill increased 5.6% year-over-year.
- Ranks #36 out of 75 companies in the Health Care sector.
- Peak goodwill was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.5M | +5.6% |
| FY2024 | $107.5M | -15.7% |
| FY2023 | $127.5M | -3.1% |
| FY2022 | $131.5M | +0.0% |
| FY2021 | $131.5M | -2.9% |
| FY2020 | $135.4M | +160.5% |
| FY2019 | $52.0M | -3.0% |
| FY2018 | $53.6M | +3.7% |
| FY2017 | $51.7M | -2.6% |
| FY2016 | $53.1M | -2.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026